Clinical trials
Phase 1/2 Wet Macular Degeneration trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| 4D Molecular Therapeutics | 1 |
| Boehringer Ingelheim | 1 |
| Elisigen, Inc. | 1 |
| Lions Eye Institute, Perth, Western Australia | 1 |
| Southern California Desert Retina Consultants, MC | 1 |
| Tyrogenex | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Wet Macular Degeneration | 6 |
| Macular Degeneration | 4 |
| Eye Diseases | 2 |
| Retinal Degeneration | 2 |
| Retinal Diseases | 2 |
| Choroidal Neovascularization | 1 |
| Glycogen Storage Disease Type II | 1 |
| Retinal Neovascularization | 1 |
Trials
Showing 76 to 6 of 6. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.